Determinants of cancer screening frequency: The example of screening for cervical cancer

Journal of the American Board of Family Practice

Volumn 11, Issue 2, 1998, Pages 87-95

  Frame, Paul S ^a,b   Sutherland Frame, J ^c  

^a Tri County Family Medicine   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE COURSE; FEMALE; HUMAN; MASS SCREENING; METHODOLOGY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICS; TIME; UNITED STATES; UTERINE CERVIX TUMOR; VAGINA SMEAR;

DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; FEMALE; HUMANS; MASS SCREENING; MODELS, STATISTICAL; SENSITIVITY AND SPECIFICITY; TIME FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0032011034     PISSN: 08938652     EISSN: None     Source Type: Journal    
DOI: 10.3122/15572625-11-2-87     Document Type: Article

References (27)

1. US Preventive Services Task Force. Guide to clinical preventive services: report of the US Preventive Services Task Force. 2nd ed. Baltimore: Williams & Wilkins, 1996.
2. Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Ottawa, Canada: Canada Communications Group, 1994.
3. Eddy DM, editor. Common screening tests. Philadelphia: American College of Physicians, 1992.
4. Commission on Public Health and Scientific Affairs. Age charts for periodic health examination. Kansas City, Mo: American Academy of Family Physicians, 1993.
5. Shingleton HM, Patrick RL, Johnston WW, Smith RA. The current status of the Papanicolaou smear. Ca Cancer J Clin 1995;45:305-20.
6. Guidelines for the cancer-related checkup: an update. Atlanta: American Cancer Society, 1993.
7. Recommendations on frequency of Pap test screening. Committee on Gynecologic Practice, American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 1995;49:210-1.
8. Knox EG. Ages and frequencies for cervical cancer screening. Br J Cancer 1976;34:444-52.
9. Richart RM, Barron BA. Screening strategies for cervical cancer and cervical intraepithelial neoplasia. Cancer 1981(5 Suppl);47:1176-81.
10. Lieu D. The Papanicolaou smear: its value and limitations. J Fam Pract 1996;42:391-9.
11. Slawson DC, Bennett JH, Herman JM. Follow-up Papanicolaou smear for cervical atypia: are we missing significant disease? A HARNET study. J Fam Pract 1993;36:289-93.
12. Hocutt JE Jr, Clark RR, Pfenninger JL, Queripel P. Papanicolaou testing and colposcopic screening. J Fam Pract 1992;34:38-40.
13. Eddy DM. Screening for cervical cancer. Ann Intern Med 1990;113:214-26.
14. Dehner LP. Cervicovaginal cytology, false-negative results, and standards of practice. Am J Clin Pathol 1993;99:45-7.
15. Gay JD, Donaldson LD, Goellner JR. False-negative results in cervical cytologic studies. Acta Cytol 1985;29:1043-6.
16. Soost HJ, Lange HJ, Lehmacher W, Ruffing-Kullmann B. The validation of cervical cytology. Sensitivity, specificity and predictive values. Acta Cytol 1991;35:8-14.
17. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186-92.
18. Richart RM, Barron BA. A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol 1969;105:386-93.
19. Fidler HK, Boyes DA, Worth AJ. Cervical cancer detection in British Columbia: a progress report. J Obstet Gynaecol Br Commonw 1968;75:392-404.
20. Barron BA, Cahill MC, Richart RM. A statistical model of the natural history of cervical neoplastic disease: the duration of carcinoma in-situ. Gynecol Oncol 1978;6:196-205.
21. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes. Br Med J Clin Res Ed 1986;293:659-64.
22. Shun-Zhang Y, Miller AB, Sherman GJ. Optimising the age, number of tests, and test interval for cervical screening in Canada. J Epidemiol Community Health 1982;36:1-10.
23. Carmichael JA, Clarke DH, Moher D, Ohlke ID, Karchmar EJ. Cervical carcinoma in women aged 34 and younger. Am J Obstet Gynecol 1986;154:264-9.
24. Taubes G. The breast-screening brawl. Science 1997;275:1056-9.
25. Kiernan GN, Frame PS. Cancer occurrence and screening in family practice: a 20-year experience. J Fam Pract 1996;43:49-55.
26. Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomized trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;1:829-32.
27. Shaprio S. Evidence on screening for breast cancer from a randomized trial. Cancer 1977;39:2772-82.